JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Bread Financial
BFH
$4.51B
| $7.68M | ﹤0.01% |
85,747
+52,460
| +158% | +$4.63M |
|
2252
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
| $7.67M | ﹤0.01% |
69,035
-654
| -0.9% | -$69.8K |
|
2253
Delek Logistics
DKL
$2.78B
| $7.65M | ﹤0.01% |
239,497
+7,284
| +3% | +$231K |
|
2254
Xencor
XNCR
$1.71B
| $7.65M | ﹤0.01% |
222,537
-17,738
| -7% | -$648K |
|
|
KW
2255
DELISTED
Kennedy-Wilson Holdings
KW
| $7.65M | ﹤0.01% |
342,860
+79,059
| +30% | +$1.77M |
|
2256
Vanguard Global ex-US Real Estate ETF
VNQI
$3.52B
| $7.65M | ﹤0.01% |
129,411
+2,570
| +2% | +$154K |
|
|
AYX
2257
DELISTED
Alteryx Inc
AYX
| $7.64M | ﹤0.01% |
76,403
-382,256
| -83% | -$38.8M |
|
2258
PUT
Consolidated Edison
ED
$40.1B
| $7.6M | ﹤0.01% |
84,000
-8,300
| -9% | -$744K |
|
2259
Usana Health Sciences
USNA
$252M
| $7.59M | ﹤0.01% |
96,641
+33,636
| +53% | +$2.48M |
|
2260
MillerKnoll
MLKN
$1.62B
| $7.58M | ﹤0.01% |
182,058
-345,307
| -65% | -$16M |
|
2261
nVent Electric
NVT
$27.5B
| $7.57M | ﹤0.01% |
295,898
-307,760
| -51% | -$7.15M |
|
2262
Chewy
CHWY
$9.2B
| $7.55M | ﹤0.01% |
260,367
-101,642
| -28% | -$2.6M |
|
|
AJRD
2263
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $7.53M | ﹤0.01% |
164,992
+116,188
| +238% | +$5.26M |
|
|
VBTX
2264
DELISTED
Veritex Holdings
VBTX
| $7.53M | ﹤0.01% |
258,477
+10,628
| +4% | +$273K |
|
|
RUBY
2265
DELISTED
Rubius Therapeutics, Inc
RUBY
| $7.53M | ﹤0.01% |
792,152
+49,819
| +7% | +$482K |
|
2266
CALL
Waste Management
WM
$89.6B
| $7.52M | ﹤0.01% |
66,000
+36,000
| +120% | +$4.07M |
|
2267
Eagle Materials
EXP
$6.41B
| $7.51M | ﹤0.01% |
82,899
-64,818
| -44% | -$5.94M |
|
2268
Invesco KBW Bank ETF
KBWB
$6.84B
| $7.51M | ﹤0.01% |
128,973
-848,320
| -87% | -$46.7M |
|
2269
PUT
Elevance Health
ELV
$86.4B
| $7.49M | ﹤0.01% |
24,800
| – | – |
|
2270
CALL
Boyd Gaming
BYD
$6.05B
| $7.49M | ﹤0.01% |
250,000
+100,000
| +67% | +$2.81M |
|
2271
Eldorado Gold
EGO
$10B
| $7.48M | ﹤0.01% |
931,739
-1,386,983
| -60% | -$10.7M |
|
|
ARNA
2272
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.46M | ﹤0.01% |
164,330
+35,446
| +28% | +$1.68M |
|
2273
Box
BOX
$4.66B
| $7.46M | ﹤0.01% |
444,719
+99,677
| +29% | +$1.67M |
|
2274
CALL
Snap
SNAP
$8.96B
| $7.46M | ﹤0.01% |
456,900
+56,900
| +14% | +$837K |
|
2275
PUT
Ferrari
RACE
$72.5B
| $7.45M | ﹤0.01% |
45,000
-210,000
| -82% | -$34M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.